Bristol Hospice has been a prolific buyer in the hospice M&A market, but the company is now leaning heavily into its de novo strategy.The Salt Lake City-based hospice provider opened double-digit numbers of de novos last year with expectations of doing the same in 2024. Bristol Hospice, which is backed by the private equity firm […]
